The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Abstract
Great emphasis is being placed on identification of neurotransmitter systems involved in the symptomatic manifestations of neurological and psychiatric disorders. In the case of Alzheimer's disease, which now seems to be one of the most common causes of mental deterioration in the elderly, compelling evidence has been developed that acetylcholine-releasing neurons, whose cell bodies lie in the basal forebrain, selectively degenerate. These cholinergic neurons provide widespread innervation of the cerebral cortex and related structures and appear to play an important role in cognitive functions, especially memory. These advances reflect a close interaction between experimental and clinical neuroscientists in which information derived from basic neurobiology is rapidly utilized to analyze disorders of the human brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
Self-citationSELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Self-citationHökfelt, T., Johansson, O., Ljungdahl, Å., Lundberg, J. M., & Schultzberg, M. (1980) · Nature · doi:10.1038/284515a0 · Cited by 1,547
Human Memory and the Cholinergic System: A Relationship to Aging?
Drachman, D. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320001001 · Cited by 1,397
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
BOWEN, D. M., SMITH, C. B., WHITE, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,311
Krettek, J. E., & Price, J. L. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901780204 · Cited by 1,293
Cited by
Items 201–214 of 214
Rapid Eye Movement Density is Reduced in the Normal Elderly
Darchia, N., Campbell, I. G., & Feinberg, I. (2003) · Sleep · doi:10.1093/sleep/26.8.973 · Cited by 58
Gustilo, M. C., Markowska, A. L., Breckler, S., Fleischman, C. A., Price, D. L., & Koliatsos, V. E. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990322)405:4<491::aid-cne4>3.0.co;2-n · Cited by 58
Self-citationMa, X.-H., Zhong, P., Gu, Z., Feng, J., & Yan, Z. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01159.2003 · Cited by 56
“…cholinergic system plays a crucial modulatory role in the CNS. Degeneration of basal forebrain cholinergic neurons, together with deficits in the central cholinergic system, has been linked to cognitive and memory impairment associated with Alzheimer’s disease (AD) (Coyle et al., 1983; Muir, 1997).”
BackgroundChanges in sleep theta rhythm are related to episodic memory impairment in early Alzheimer's disease
Hot, P., Rauchs, G., Bertran, F., Denise, P., Desgranges, B., Clochon, P., & Eustache, F. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.04.002 · Cited by 52
Heo, H.-J., Hong, S.-C., Cho, H.-Y., Hong, B., Kim, H.-K., Kim, E.-K., & Shin, D.-H. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15011-4 · Cited by 38
Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease
Caraci, F., Nicoletti, F., & Copani, A. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.12.001 · Cited by 37
“excitotoxicity and massively degenerate in AD [76].”
Freeburn, A., & Munn, R. G. K. (2021) · Neuronal Signaling · doi:10.1042/ns20200011 · Cited by 37
Chen, G., Chen, P., Tan, H., Ma, D., Dou, F., Feng, J., & Yan, Z. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.023 · Cited by 36
Differential effects of nicotine exposure on the hippocampus across lifespan
Zeid, D., Kutlu, M. G., & Gould, T. J. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170714092436 · Cited by 36
Alzheimer’s disease: from early pathogenesis to novel therapeutic approaches
Prajapati, S. K., Pathak, A., & Samaiya, P. K. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01389-6 · Cited by 21
GJ-4 alleviates Aβ25-35-induced memory dysfunction in mice through protecting the neurovascular unit
Zhang, Z., Liu, H., Zhao, Z., Zang, C., Ju, C., Li, F., Wang, L., Yang, H., Bao, X., Yu, Y., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110131 · Cited by 19
Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome
Caraci, F., Iulita, M. F., Pentz, R., Flores Aguilar, L., Orciani, C., Barone, C., Romano, C., Drago, F., & Cuello, A. C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.004 · Cited by 18
Capsoni, S., Arisi, I., Malerba, F., D’Onofrio, M., Cattaneo, A., & Cherubini, E. (2022) · Brain Sciences · doi:10.3390/brainsci12060783 · Cited by 18
Wu, Y., Gao, Y., Tie, F., Wang, R., Hu, N., Dong, Q., Fu, C., & Wang, H. (2025) · Molecules · doi:10.3390/molecules30183686 · Cited by 6
Metadata
- Authors
- Coyle, J. T., Price, D. L., & DeLong, M. R.
- Venue
- Science
- Published
- 1983-03-11
- Volume
- 219
- Issue
- 4589
- Pages
- 1184-1190
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2021280501
- Cited by
- 3,052
- References
- 92
- FWCI
- 124.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.